Arjun Balaji is a Partner focused on investing and research at Paradigm, one of crypto’s most active venture firms, where his work spans backing early-stage protocols and building the firm’s own trading infrastructure. He joined Paradigm’s investment team in 2019 after building a reputation as an independent cryptocurrency analyst advising New York hedge funds and family offices on allocation models, mining, and derivatives.
His recent work includes steering Paradigm’s restaking bet, Symbiotic, and leading a prediction-markets trading terminal, reported in April 2026. He holds a degree in computer science from Northeastern University.
Who Is Arjun Balaji?
Arjun Balaji holds a B.S. in Computer Science from Northeastern University, according to a Bloomberg profile of him. Before moving into venture investing, he spent several years as an independent cryptocurrency analyst, consulting with New York-based hedge funds and family offices on allocation models, mining operations, and derivatives. That work meant getting fluent early in how Bitcoin’s public ledger actually functions, the same ground our crypto guide covers for readers newer to the topic.
Before joining Paradigm, Balaji built a name for himself as a crypto researcher and writer. The Block founder Mike Dudas named him as the outlet’s technical advisor in a January 2019 interview, crediting him with an upcoming piece on the Lightning Network. That pairing of markets consulting and public writing became something of a calling card ahead of the move that would define his career.
Balaji joined Paradigm’s investment team in 2019, the same firm co-founded by Fred Ehrsam and Matt Huang, according to CoinDesk. The move gave his sourcing instincts, sharpened through years of independent research, an institutional platform focused on public blockchains and early-stage crypto investment.
Arjun Balaji’s Career and Contributions
At Paradigm, Balaji works alongside a small team of partners steering one of crypto’s most closely watched venture portfolios, with a stated focus on cryptocurrency markets and investments in public blockchains.
His most visible bet has been Symbiotic, a restaking protocol Paradigm helped launch with a $5.8 million seed round in June 2024, according to The Block, before it grew into a $29 million Series A led by Pantera Capital in 2025. By June 2026, CoinDesk reported that Symbiotic had launched Liquid Lane, letting institutions swap tokenized real-world assets for stablecoins without waiting through redemption windows.
Balaji has also backed consumer-facing crypto products. In 2021, Paradigm supported a $7.6 million raise for Showtime, an NFT social network, with Balaji speaking publicly at the time about the firm’s confidence in the founder’s vision for a creator-owned platform. Most recently, he has moved from backing outside teams to building in-house, leading Paradigm’s own prediction markets trading terminal, detailed below.
Arjun Balaji’s Investment Thesis and Views
Balaji’s public commentary points to an investor drawn to founder conviction as much as market timing. Announcing Paradigm’s backing of Showtime in 2021, he told CoinDesk, “Paradigm is inspired by Alex’s vision of building a user-owned NFT social network, and we’re excited to support the Showtime team”.
Neither Balaji nor Paradigm has laid out a public framework for which markets the firm enters next. What the reporting on Symbiotic and the prediction markets terminal shows is a pattern of building infrastructure in-house once conviction in a category is already there.
Arjun Balaji in the News
The most notable recent reporting on Balaji centers on Paradigm’s push into prediction markets. The Block reported on April 1, 2026 that Paradigm is developing a dedicated prediction markets trading terminal for professional traders and market makers, with Balaji leading the project since late 2025.
The outlet also noted Paradigm has considered an internal market-making desk for the category and has already backed Kalshi through multiple funding rounds, including a $1 billion Series E in December 2025 at an $11 billion valuation. Balaji did not respond to a request for comment on the reporting, and a Paradigm spokesperson declined to comment on the terminal project.
Frequently Asked Questions
Need a refresher on Arjun Balaji? Here are the questions readers most often ask about him.
What is Symbiotic, the project Arjun Balaji helped fund?
Symbiotic is a restaking protocol that Paradigm backed with a $5.8 million seed round in 2024, according to The Block. It launched as a direct competitor to EigenLayer before expanding into what it calls a universal staking protocol, letting a range of blockchain networks secure themselves with shared collateral instead of building security infrastructure from scratch.
What has Arjun Balaji invested in at Paradigm?
Balaji has worked on Paradigm’s backing of the restaking protocol Symbiotic, the NFT platform Showtime, and, more recently, the firm’s own in-house prediction markets trading terminal.
Is Arjun Balaji a co-founder of Paradigm?
No. Paradigm was founded by Fred Ehrsam and Matt Huang, according to CoinDesk. Balaji joined the investment team in 2019 as a Partner, not as one of the firm’s founders.
Is Arjun Balaji still working on prediction markets in 2026?
As of April 2026, the most recent reporting on the project, Balaji was still leading Paradigm’s prediction markets trading terminal, with The Block noting the firm was also weighing an internal market-making desk for the category.
